To Incorporate Third Generation Sequencing into Clinical In Vitro Diagnostics Platform. Ghent, Belgium – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they have been awarded a 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop a clinical in vitro diagnostics (IVD) platform incorporating third generation sequencing (TGS) technologies. The project, […]

State-of-the-art site will enable rapid delivery of engineered cell lines Powering ready-to-use edited cell-line portfolio expansion Enable comprehensive customization for research, diagnostic and therapeutic development Cambridge, UK – Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility in Fremont, CA, which will serve […]

The first completely reusable 3D cell culture microplate on the market Montreal, Canada – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use plastics – from serological pipettes and pipette tips to vials and culture microplates – these […]

Nikolai Slavov is a professor at Northeastern University and an Allen Distinguished Investigator. LOS ANGELES, CA, UNITED STATES, — Dr. Nikolai Slavov, Professor at Northeastern University and an Allen Distinguished Investigator, officially joined the Scientific Advisory Board of ProtiFi, LLC Thursday December 3rd, 2020. Prof. Dr. Slavov has pioneered high- throughput mass-spectrometry methods for quantifying […]

• T-cell response has the potential to give a clearer picture of immunity and course of illness • T-cell response to SARS-CoV-2 may decline less rapidly than antibodies • Potentially vital tool for research into immune response and vaccination efficacy Hilden, Germany and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today […]

Company’s intelligent microfluidics platform can identify virtually any cell type, at frequencies as low as one in a billion MOUNTAIN VIEW, Calif. − Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that it has closed its Series A round of financing with $20 million, […]

Amsterdam, the Netherlands —  In their quest of creating safe and effective immunotherapy cancer treatments, LUMICKS and LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell Avidity Analyzer. LAVA Therapeutics […]

GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology company, a spin-off from South Korean biotech company Tiumbio, seeking antibody-based therapeutics for patients who are suffering from unaddressed incurable and rare diseases. The strategic collaboration […]

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology.  These include the release of new improvements in PromethION flow cells that have enabled a new 10 Terabase sequencing record, modal single-read accuracy of 99.1% using a new sequencing chemistry currently in development, high accuracy variant calling tools and automation options for nanopore sequencing experiments at any scale. Further […]

– Supporting drug development research through the use of HCA and three-dimensional culture models – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has entered into a partnership agreement with InSphero AG, a pioneer in the development of 3D in vitro*1 technologies for drug discovery and safety. The two companies aim to establish […]